Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22901886 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
Condition: Asthma
Interventions: Biological: Mepolizumab 750;   Biological: Mepolizumab 250;   Biological: Mepolizumab 75;   Drug: Placebo saline

Indicates status has not been verified in more than two years